27615-1-AP

antibody from Proteintech Group

Targeting: E2F3

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Antibody Data

Product number

27615-1-AP

Provider

Proteintech Group

Product name

E2F3 antibody

Antibody type

Polyclonal

Description

E2F3 antibody (Cat. #27615-1-AP) is a rabbit polyclonal antibody that shows reactivity with Human and has been validated for the following applications: WB,ELISA.

Reactivity

Human

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivity.

Wurm AA, Brilloff S, Kolovich S, Schäfer S, Rahimian E, Kufrin V, Bill M, Carrero ZI, Drukewitz S, Krüger A, Hüther M, Uhrig S, Oster S, Westphal D, Meier F, Pfütze K, Hübschmann D, Horak P, Kreutzfeldt S, Richter D, Schröck E, Baretton G, Heining C, Möhrmann L, Fröhling S, Ball CR, Glimm H
Cell reports. Medicine 2023 Oct 17;4(10):101200

---

Brevilin A shows an anti-tumor role in prostate cancer via the lncRNA H19/miR-194/E2F3 signaling pathway.

You P, Tang L, Zhu Y, Tian Y
Aging 2023 May 30;15(10):4411-4428

---

Loss of exosomal miR-200b-3p from hypoxia cancer-associated fibroblasts promotes tumorigenesis and reduces sensitivity to 5-Flourouracil in colorectal cancer via upregulation of ZEB1 and E2F3.

Gong W, Guo Y, Yuan H, Chai R, Wan Z, Zheng B, Hu X, Chen B, Gao S, Dai Q, Yu P, Tu S
Cancer gene therapy 2023 Jun;30(6):905-916

---

Identification of a novel prognostic signature composed of 3 cuproptosis-related transcription factors in colon adenocarcinoma.

Zhou L, Zhang Y, Xu Y, Jiang T, Tang L
Genes & genomics 2023 Aug;45(8):1047-1061

---

rtcisE2F promotes the self-renewal and metastasis of liver tumor-initiating cells via N(6)-methyladenosine-dependent E2F3/E2F6 mRNA stability.

Chen Z, Huang L, Wang K, Zhang L, Zhong X, Yan Z, Liu B, Zhu P
Science China. Life sciences 2022 Sep;65(9):1840-1854

---

IGF2BP3 enhances the mRNA stability of E2F3 by interacting with LINC00958 to promote endometrial carcinoma progression.

Wang C, Kong F, Ma J, Miao J, Su P, Yang H, Li Q, Ma X
Cell death discovery 2022 Jun 8;8(1):279

---

MicroRNA‑141 inhibits the differentiation of bone marrow‑derived mesenchymal stem cells in steroid‑induced osteonecrosis via E2F3.

Xue F, Wu J, Feng W, Hao T, Liu Y, Wang W
Molecular medicine reports 2022 Jul;26(1)

---

miRNA in food simultaneously controls animal viral disease and human tumorigenesis.

Cui Y, Wan H, Zhang X
Molecular therapy. Nucleic acids 2021 Mar 5;23:995-1006

---

Apigenin inhibits the growth of colorectal cancer through down-regulation of E2F1/3 by miRNA-215-5p.

Cheng Y, Han X, Mo F, Zeng H, Zhao Y, Wang H, Zheng Y, Ma X
Phytomedicine : international journal of phytotherapy and phytopharmacology 2021 Aug;89:153603

---

MicroRNA‑145‑5p inhibits osteosarcoma cell proliferation by targeting E2F transcription factor 3.

Li H, Pan R, Lu Q, Ren C, Sun J, Wu H, Wen J, Chen H
International journal of molecular medicine 2020 May;45(5):1317-1326

---

SNHG1 promotes cell proliferation by acting as a sponge of miR-145 in colorectal cancer.

Tian T, Qiu R, Qiu X
Oncotarget 2018 Jan 5;9(2):2128-2139

---

Shrimp miR-34 from Shrimp Stress Response to Virus Infection Suppresses Tumorigenesis of Breast Cancer.

Cui Y, Yang X, Zhang X
Molecular therapy. Nucleic acids 2017 Dec 15;9:387-398

---

Dihydroartemisinin suppresses pancreatic cancer cells via a microRNA-mRNA regulatory network.

Li Y, Wang Y, Kong R, Xue D, Pan S, Chen H, Sun B
Oncotarget 2016 Sep 20;7(38):62460-62473